JPRN-jRCT1051200143
Recruiting
Phase 4
Prospective cohort study of effectiveness and safety of COVID-19 vaccines in Osaka, Japan
Kayeka Hiroshi0 sites1,500 target enrollmentMarch 3, 2021
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kayeka Hiroshi
- Enrollment
- 1500
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Those who meet all of the following 1\), 2\), and 3\)
- •1\) Persons who meet any of the following (a) to (d)
- •(a) Health care workers at Osaka City (Metropolitan) University Hospital
- •(b) Staff of Osaka City Health Bureau \*
- •(c) Faculty / Students of Osaka City (Metropolitan) University School of Medicine / Graduate School of Medicine / Graduate School of Nursing
- •(d) Member of Osaka Clinical Trial Volunteer Association, Osaka City (Metropolitan) University Hospital \#
- •\* Including Osaka City Health Center
- •\# They will be recruited If the expected number of subjects will not be achieved from (a), (b), and (c)
- •2\) Aged 20\-64 years
- •3\) Persons who have voluntarily provided written informed consent for participation
Exclusion Criteria
- •Persons who meet any of the following 1\) to 4\)
- •1\) Those with contraindications for vaccination
- •2\) Those who have been received with COVID\-19 vaccines in the past (including participation in clinical trials or clinical studies)
- •3\) Those who have been diagnosed with COVID\-19 in the past
- •4\) Those who are judged to be ineligible for research by the principal investigator or the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective Cohort Study on efficacy and safety of transcutaneous minocycline (MINO) injection therapy for patients of simple giant hepatic cysts.Simple giant hepatic cystsJPRN-UMIN000012044ational Center for Global Health and Medicine, Department of Gastroenterology10
Recruiting
Not Applicable
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients with Muti-gene assayHER2 Positive Elderly Breast Cancer PatientsJPRN-UMIN000051581Public Health Research Foundation266
Completed
Phase 3
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer PatientsHER2 positive primary breast cancer in elderlyJPRN-UMIN000028476RESPECT executive committee300
Active, not recruiting
Phase 1
Same as aboveEUCTR2020-006003-42-DKCHIP - Rigshospitalet - University of Copenhagen10,000
Completed
Not Applicable
Prospective cohort study for safety and efficacy of low dose nab-paclitaxelBreast cancerJPRN-UMIN000013275Department of Surgical Oncology Osaka City University Graduate School of Medicine20